| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/09/2006 | US7041687 Indazole compounds useful as protein kinase inhibitors |
| 05/09/2006 | US7041685 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/09/2006 | US7041684 4-[2-Hydroxy-3-([4-(5-carbamoyl-2-pyridyloxy)phenyl]-2-methylpropylamino)propoxy]carbazole and salts;treating obesity; antidiabetic agent for non-insulin dependent diabetes (Type II); |
| 05/09/2006 | US7041682 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 05/09/2006 | US7041681 Nitrogen heterocyclic compounds, e.g., 3-(2-oxo-2-phenyl-ethylcarbamoyl)-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester; treating pain and gastrointestinal disorders. |
| 05/09/2006 | US7041680 (R) and (S) isomers of substituted 2-(2,6-dioxopiperidin-3-yl) phthalimides and 1-oxoisoindolines and methods of using the same |
| 05/09/2006 | US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |
| 05/09/2006 | US7041665 Central nervous system disorders; anxiolytic agents; antidepressants; antiepilepsy agents; antiarthritic agents |
| 05/09/2006 | US7041662 Substituted benzo [b] azepin-2-one compounds |
| 05/09/2006 | US7041659 Compounds for the treatment of metabolic disorders |
| 05/09/2006 | US7041651 Cellular uptake of bioactive agents |
| 05/09/2006 | US7041461 Nucleotide sequences coding membrame protein for use in analgesics |
| 05/09/2006 | US7041316 Stable oral pharmaceutical dosage forms |
| 05/09/2006 | US7041313 e.g., pantoprazole; combination of one administration form that is the drug with a disintegrant and a sustained-release coating of a water-insoluble and plastic membrane with low swelling power in water and in which small soluble particles are embedded and other form is the drug with an enteric coating |
| 05/09/2006 | US7041311 Preparation for saliva flow |
| 05/09/2006 | US7040314 Aerosol generating devices and methods for generating aerosols suitable for forming propellant-free aerosols |
| 05/09/2006 | CA2418908C 1,4-dihydropyridines as bradykinin antagonists |
| 05/09/2006 | CA2322501C Processes for the preparation of (r)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 05/09/2006 | CA2262668C Inhibitors of cathepsin k |
| 05/09/2006 | CA2205573C Enterokinetic benzamide |
| 05/09/2006 | CA2173506C Enteric granule-containing tablets |
| 05/04/2006 | WO2006046977A1 Macrocyclic ghrelin receptor antagonists and methods of using the same |
| 05/04/2006 | WO2006046880A1 Nutritional and/or pharmaceutical preparation for use in prophylaxis and treatment of disturbances in microelements absorption from the alimentary canal |
| 05/04/2006 | WO2006046779A1 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof |
| 05/04/2006 | WO2006046746A1 Preventive/therapeutic agent for visceral pain |
| 05/04/2006 | WO2006046739A1 Remedy for inflammatory diseases |
| 05/04/2006 | WO2006046738A1 Process for producing indigestible dextrin containing isomerized sugar |
| 05/04/2006 | WO2006046690A1 Composition for oral cavity |
| 05/04/2006 | WO2006046674A1 Preventive and remedy for hepatitis c virus infection |
| 05/04/2006 | WO2006046492A1 Novel ppar regulating agent and method of screening the same |
| 05/04/2006 | WO2006046007A1 The treatment of inflammatory bowel disease |
| 05/04/2006 | WO2006045820A1 Pharmaceutical compositions based on nk2 antagonists for pediatric use |
| 05/04/2006 | WO2006045319A2 Uses of growth hormone secretagogues in the treatment of individuals suffering from renal and/or liver failure |
| 05/04/2006 | WO2006045313A2 Uses of secretagogues for treatment of organ transplant patients |
| 05/04/2006 | WO2006045298A2 Treatment of the consequences of alcohol abuse hepatitis pancreatitis |
| 05/04/2006 | WO2006036512A3 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 05/04/2006 | WO2005123718A3 Benzimidazolone carboxylic acid derivatives |
| 05/04/2006 | WO2005106492A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 3 (ccr3) |
| 05/04/2006 | US20060095003 Apparatus for delivery of therapeutic and/or diagnostic agents |
| 05/04/2006 | US20060094784 Tgf-alpha expression inhibitors |
| 05/04/2006 | US20060094769 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 05/04/2006 | US20060094762 Magnesium salt of imidazole derivative |
| 05/04/2006 | US20060094751 Quinuclidine derivatives and pharmaceutical compositions containing the same |
| 05/04/2006 | US20060094730 Water-soluble thalidomine derivatives |
| 05/04/2006 | US20060094727 Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |
| 05/04/2006 | US20060094725 N-heterocyclic derivatives as NOS inhibitors |
| 05/04/2006 | US20060094722 Combination drug |
| 05/04/2006 | US20060094720 NK1 antagonists |
| 05/04/2006 | US20060094691 Inclusion complexes of rosiglitazone |
| 05/04/2006 | US20060094688 Histamine release inhibitor |
| 05/04/2006 | US20060094664 Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation |
| 05/04/2006 | US20060094647 Treatment of inflammatory bowel disease using growth factors |
| 05/04/2006 | US20060094608 Mixture of polyol and insulation agent; heating upon exposure to moisture; for urogenital systems; dysmenorrhea |
| 05/04/2006 | US20060093611 from mammalian chondrocyte progenitor cells expressing mechanosensitive TWIK-related potassium (TREK) ion channels; biocompatability, in vitro |
| 05/04/2006 | US20060093585 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 05/04/2006 | US20060093574 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 05/04/2006 | DE102004052697A1 Pharmazeutische Zubereitungen zur Behandlung von Folgen des Alkoholmissbrauchs, Hepatitis, Pankreatitis, Alzheimererkrankung, Morbus Parkinson, Diabetes, toxischen Nierenerkrankungen, Reperfusionsschäden, der Arteriosklerose sowie als Antidote gegen Umweltgifte und Medikamentenintoxikation Pharmaceutical preparations for the treatment of episodes of alcohol abuse, hepatitis, pancreatitis, Alzheimer's disease, Parkinson's disease, diabetes, toxic kidney disease, reperfusion injury, atherosclerosis and as antidotes against environmental toxins and prescription drug intoxication |
| 05/04/2006 | CA2589324A1 Nutritional and/or pharmaceutical preparation for use in prophylaxis and treatment of disturbances in microelements absorption from the alimentary canal |
| 05/04/2006 | CA2585642A1 Carbazole derivatives, solvates thereof, or pharmaceutically acceptable salts thereof |
| 05/04/2006 | CA2584481A1 Pharmaceutical compositions based on nk2 antagonists for pediatric use |
| 05/04/2006 | CA2581207A1 The treatment of inflammatory bowel disease |
| 05/03/2006 | EP1652913A1 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 05/03/2006 | EP1652539A1 Method of manufacturing a stent comprising an anti-angiogenic composition |
| 05/03/2006 | EP1652515A1 Process for producing drug ultramicroparticle and apparatus therefor |
| 05/03/2006 | EP1652514A1 At-use dispersed preparation |
| 05/03/2006 | EP1651622A1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
| 05/03/2006 | EP1651621A1 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators |
| 05/03/2006 | EP1651228A1 Use of quinazoline tyrosine kinase inhibitors in the treatment of inflammatory processes |
| 05/03/2006 | EP1651217A1 Alkaline salts of proton pump inhibitors |
| 05/03/2006 | EP1651206A1 Compositions and methods for treating gastrointestinal conditions |
| 05/03/2006 | EP1553969B1 Use of ghrelin for treating malnutrition in gastrectomised individuals |
| 05/03/2006 | EP1499611A4 Process for 5- 2(r)- 1(r)- 3,5-bis(trifluoromethyl)phenyl|ethoxy|-3(s)-(4-fluorophenyl)-4-morpholinyl|methyl|-1,2-dihydro-3h-1,2,4-triazol-3-one |
| 05/03/2006 | EP1465870B1 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
| 05/03/2006 | EP1368006B1 Novel modified released formulation |
| 05/03/2006 | EP1353904B9 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/03/2006 | EP1335709B1 Capsule of cellulose derivatives such as hpmc containing benzimidazole derivatives such as omeprazole |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1232748B1 Use of substituted nitrobenzene derivatives for the treatment of diseases caused by bacteria, fungi and viruses |
| 05/03/2006 | EP1227805B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 05/03/2006 | EP1209988B1 Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said |
| 05/03/2006 | EP1139755B1 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 05/03/2006 | EP0937069B1 Piperazino derivatives as neurokinin antagonists |
| 05/03/2006 | EP0793500B1 Pharmaceutical compositions comprising nitric oxide-releasing polysaccharides |
| 05/03/2006 | CN1768071A Lipid-regulating agent and use thereof |
| 05/03/2006 | CN1768065A Thienopyrimidine compound and use of the same |
| 05/03/2006 | CN1767855A Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist |
| 05/03/2006 | CN1767845A Composition for treating hepatitis c |
| 05/03/2006 | CN1767830A The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome |
| 05/03/2006 | CN1765937A Bismuth potassium hyalurate and its preparation method and uses |
| 05/03/2006 | CN1765936A Bismuth hyalurate and its preparation method and uses |
| 05/03/2006 | CN1765934A Nanometer mushroom amylose and preparation method of its injection |
| 05/03/2006 | CN1765929A Fusion protein and nucleic acid containing peptide carrier and epidermal growth factor and its uses |
| 05/03/2006 | CN1765912A Pyracantha extract and its preparation method and uses |
| 05/03/2006 | CN1765413A Chinese medicinal capsule for treating asthenic cold type prolonged diarrhea |
| 05/03/2006 | CN1765409A Chinese herbal decoction for treating turbid phlegm stagnation pattern dizziness and preparation method |
| 05/03/2006 | CN1765406A Chinese herbal decoction for treating excessive risen liver-yang pattern dizziness and preparation method |
| 05/03/2006 | CN1765403A Chinese medicinal capsule for treating blood stasis pattern protracted diarrhea due to intestine erosion and ulcer |
| 05/03/2006 | CN1765399A Chinese herbal decoction for treating apontaneous emission of kidney-yang deficiency pattern and preparation method |
| 05/03/2006 | CN1765398A Chinese medicinal pill for treating damp heat pattern protracted diarrhea |
| 05/03/2006 | CN1765397A Chinese herbal decoction for treating kidney-essence deficiency pattern dizziness and preparation method |